Annual Drug Patent Expirations for PROAIR+DIGIHALER
Proair Digihaler is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from two suppliers. There are nineteen patents protecting this drug.
Drug patent litigation for PROAIR DIGIHALER.
This drug has two hundred and ninety-nine patent family members in thirty-one countries.
The generic ingredient in PROAIR DIGIHALER is albuterol sulfate. Two suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
